Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00348634
Status:
TERMINATED
Last Update Posted:
2016-03-04
First Post:
2006-07-03
Brief Title:
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
Status:
TERMINATED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Terminated early due to regulatory action suspending tegaserod use in 2007
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None